The approval of Spravato nasal spray to help tackle treatment-resistant depression marks the first time the FDA has approved its active ingredient, esketamine, for any use.
As generic drugs are placed on higher, non-generic tiers, patient cost sharing for these medications can increase, according to a recent study from Avalere.
The Food and Drug Administration has approved Glenmark's generic Micardis, which had a market value of roughly $40.6 million for the 12-month period ended January 2019.
New web-based CE courses that will be delivered through ProCE include modules on prostate cancer, nutrition and cancer care, complex disease states, and chronic inflammatory/autoimmune diseases.
National Association of Chain Drug Stores president and CEO Steve Anderson discussed in an op-ed pharmacists' expanded role in cardiovascular disease during American Heart Month.
